Preferential drug delivery to tumor cells than normal cells using a tunable niosome –chitosan double package nanodelivery system: a novel in vitro model

ConclusionBased on the observation of the DDS preferentially targeting tumor cells, there is a potential implication for the localized delivery of therapeutic drug doses to solid tumors or post-surgical solid tumors cavities containing residual tumor cells.
Source: Cancer Nanotechnology - Category: Cancer & Oncology Source Type: research